StockData
Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc. (VERA) stock

VERANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$26.20−0.77 (-2.86%)

Close on Nov 17, 2026Market cap $1.89BP/E –Yield –

Vera Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Vera Therapeutics's price to book ratio was 5.1× on Nov 11, 2026, against 5.3× a year earlier. Over the last 5 years it ranged from 1.6× to 19.8×, with a median of 4.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.1×−2.9
2025Dec 31, 20258.0×+0.5
2024Dec 31, 20247.5×+2.7
2023Dec 29, 20234.8×+0.2
2022Dec 30, 20224.6×+2.0
2021Dec 31, 20212.5×–

More Vera Therapeutics figures

See a number that looks wrong?